Description
A negative modulator of AMPA receptors containing TARP-γ8; inhibits glutamate-induced calcium flux in HEK293F cells co-transfected with TARP-γ8 and either GluA1o, GluA1i, GluA2i, GluA3o, or GluA4o (IC50s = 11.22, 12.3, 7.41, 38.02, and 15.85 nM, respectively); selective for GluA1o receptors containing TARP-γ8 over GluA1o receptors containing TARP-γ2, -γ3, -γ4, or -γ7 (IC50s = >10 μM for all); reduces peak glutamate-induced currents in acutely dissociated murine hippocampal neurons to 60.7% of control cells at 1 μM; reduces fEPSPs in the hippocampal CA1 region from wild-type, but not TARP-γ8 knockout, mice at 1 μM; inhibits corneal kindling-induced seizures in mice (ED50 = 3.7 mg/kg)
Formal name: 5-[2-chloro-6-(trifluoromethoxy)phenyl]-1,3-dihydro-2H-benzimidazol-2-one
Synonyms:
Molecular weight: 328.7
CAS: 2036081-86-2
Purity: ≥98%
Formulation: A crystalline solid
